Samsung invests in Generate: Biomedicines to advance AI-driven protein therapeutics discovery
Samsung announced today it has invested in Generate: Biomedicines (“Generate”) as part of its efforts to drive growth and innovation in the biopharmaceutical sector. The investment was made via...

